Top Markets
#1 CyberDEX CyberDEX +281.44%
#2 PulseChain PulseChain +51.36%
#3 Quack AI Quack AI +35.03%
#4 Zano Zano +27.86%
#5 DoubleZero DoubleZero +23.68%
#6 Pearl Pearl +19.82%
#7 Jelly-My-Jelly Jelly-My-Jelly +16.25%
#8 DogBull DogBull +15.10%
#9 Black Phoenix Black Phoenix +14.20%
#10 WAX WAX +12.74%
Coin of the day
CyberDEX CyberDEX
Settings
Language
ENGLISH
Currency
USD
Theme
OptiBiotix Health Plc OptiBiotix Health Plc

OptiBiotix Health Plc

OPTI
Rank in Stocks #40732
OptiBiotix Health Plc, a life sciences enterprise headquartered in York, United... OptiBiotix Health Plc, a life sciences enterprise headquartered in York, United Kingdom, specializes in the discovery and advancement of microbiome-modulating technologies. The company formulates distinct microbial strains, innovative compounds, and tailored blends intended for integration into food products, nutritional supplements, and active ingredients. Their groundbreaking work aims to positively influence human physiology and yield substantial health benefits. Among its diverse product portfolio are Slimbiome, a natural ingredient for healthy and satiety-driven weight management, and SlimBiome Medical, a supplemental aid for weight control. Other offerings include CholBiome, a dietary supplement for maintaining healthy cholesterol; Lactobacillus plantarum LPLDL, a probiotic supporting cardiovascular health and overall well-being; LPGOS, a galactooligosaccharide utilized in food applications to mitigate cardiovascular risk factors and enhance general health; WellBiome, a functional fiber and mineral blend designed to bolster gut microbiome diversity and promote wellness; and Sweetbiotix, a sweetener for use in various foods and beverages. Ultimately, OptiBiotix's innovations are designed to prevent and manage prevalent chronic lifestyle diseases, including obesity, high cholesterol, and diabetes. The company was founded in 2012.
Share Price
$0.07994122
Last synced: 2026-09-25
Market Cap
$82.58K
Change (1 day)
0.43%
Change (1 year)
-44.51%
Country
GB
Trade OptiBiotix Health Plc (OPTI)

Category

Healthcare
Revenue for OptiBiotix Health Plc (OPTI)
Revenue in Jun 2026 TTM: $1.75M
According to OptiBiotix Health Plc latest financial reports the company's current revenue (TTM) is $1.75M. In 2023 the company made a revenue of $819.81K an increase over the revenue in the year 2022 that was $552.88K. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for OptiBiotix Health Plc from 2007 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) $1.75M 60.54%
2024 $1.09M 33.16%
2023 $819.81K 48.28%
2022 $552.88K -81.52%
2021 $2.99M 43.69%
2020 $2.08M 110.80%
2019 $987.78K 50.50%
2018 $656.34K 153.86%
2017 $258.54K -28.31%
2016 $360.63K 749.11%
2015 $42.47K 0.00%
2014 0.00 0.00%
2013 0.00 -100.00%
2012 $253.34K 114.67%
2011 $118.01K 0.00%
2010 0.00 0.00%
2009 0.00 0.00%
2008 0.00 0.00%
2007 0.00 0.00%
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B 720,225.13%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B 127,026.60%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B 343,466.34%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B 898,249.57%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH